Corporate Outline

tella, Inc.

Company name tella, Inc.
Address 1F Mitsuihanagiri Bldg, 7-22-36 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023
TEL: +81-3-5937-2111
FAX: +81-3-5937-2112
Capital Amount JPY 2,184 million yen(as of December 2018)
Directors and Corporate Auditors President : Sei-ichi Yusa
Director of the Board : Yuichiro Yazaki
Director of the Board : Tadashi Matsumoto
Director of the Board : Tomosada Yoshikawa
Corporate Auditor (full-time) : Nobuo Endo
Corporate Auditor : Yasuteru Imazu
Corporate Auditor : Takafumi Eguro
Chief Scientific Advisor : Naohide Yamashita
Principal Business Activities
  • ・Provision of techniques and operational knowhow associated with cell medicines, including dendritic cell vaccine therapy, to affiliated medical institutions.
  • ・Research and Development of regenerative medicine and cell medicine,including dendritic cell vaccine therapy.
Subsidiaries TITAN Inc.
Tella Pharma, Inc.
AllGene, Inc.